Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial
- Author
- Els Mehuys (UGent) , Lucas Van Bortel (UGent) , Leen De Bolle (UGent) , Inge Van Tongelen (UGent) , Lieven Annemans (UGent) , Jean Paul Remon (UGent) and Mimi Giri (UGent)
- Organization
- Abstract
- What is known and Objective: There is little evidence from well-designed randomized controlled trials of the impact of community pharmacist intervention on the clinical management of patients with type 2 diabetes. It is also not known how sustainable any observed effects on glycaemic control are, over time. This study was initiated to address both these issues. Methods: A 6-month, randomized, controlled parallel-group trial in 66 community pharmacies was conducted in Belgium. Patients were randomly assigned to receive usual pharmacist care (n = 135) or a predefined pharmacist intervention (n = 153). The intervention mainly focused on correct medication use, medication adherence and healthy lifestyle promotion. Primary outcome was glycaemic control, as measured by fasting plasma glucose and HbA1c. Sustainability of changes in glycaemic control was assessed by additional glucose measurements 18 months after the end of the study. Results and Discussion: The intervention significantly reduced HbA1c (between-group difference: 0.5%, P = 0.009). The largest impact on HbA1c was observed when pharmacotherapy changes (i.e., type and/or dose of hypoglycaemic agents) initiated by the physician were sustained with pharmaceutical care: HbA1c was reduced by 1.05% in the intervention group, whose medication was changed, compared with a reduction of 0.02% in the therapy-modification only, group. It was also found that the diabetes education program resulted in improved self-management and better knowledge of diabetes. Eighteen months after the end of the formal study period, the mean HbA1c of the intervention group did not differ significantly from the control group (7.4% vs. 7.2%). What is new and Conclusion: This study provides new evidence, from a randomized controlled trial, of the beneficial effect of community pharmacist intervention in the clinical management of type 2 diabetic patients. However, questions remain about the sustainability of the observed improvements.
- Keywords
- pharmaceutical care, community pharmacy, randomized controlled trial, type 2 diabetes, PHARMACEUTICAL CARE, DRUG-THERAPY, MANAGEMENT, MEDICATION, ADHERENCE, QUALITY, MODEL
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 218.72 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-2014474
- MLA
- Mehuys, Els, et al. “Effectiveness of a Community Pharmacist Intervention in Diabetes Care: A Randomized Controlled Trial.” JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol. 36, no. 5, 2011, pp. 602–13, doi:10.1111/j.1365-2710.2010.01218.x.
- APA
- Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J. P., & Giri, M. (2011). Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 36(5), 602–613. https://doi.org/10.1111/j.1365-2710.2010.01218.x
- Chicago author-date
- Mehuys, Els, Lucas Van Bortel, Leen De Bolle, Inge Van Tongelen, Lieven Annemans, Jean Paul Remon, and Mimi Giri. 2011. “Effectiveness of a Community Pharmacist Intervention in Diabetes Care: A Randomized Controlled Trial.” JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 36 (5): 602–13. https://doi.org/10.1111/j.1365-2710.2010.01218.x.
- Chicago author-date (all authors)
- Mehuys, Els, Lucas Van Bortel, Leen De Bolle, Inge Van Tongelen, Lieven Annemans, Jean Paul Remon, and Mimi Giri. 2011. “Effectiveness of a Community Pharmacist Intervention in Diabetes Care: A Randomized Controlled Trial.” JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 36 (5): 602–613. doi:10.1111/j.1365-2710.2010.01218.x.
- Vancouver
- 1.Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2011;36(5):602–13.
- IEEE
- [1]E. Mehuys et al., “Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial,” JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol. 36, no. 5, pp. 602–613, 2011.
@article{2014474, abstract = {{What is known and Objective: There is little evidence from well-designed randomized controlled trials of the impact of community pharmacist intervention on the clinical management of patients with type 2 diabetes. It is also not known how sustainable any observed effects on glycaemic control are, over time. This study was initiated to address both these issues. Methods: A 6-month, randomized, controlled parallel-group trial in 66 community pharmacies was conducted in Belgium. Patients were randomly assigned to receive usual pharmacist care (n = 135) or a predefined pharmacist intervention (n = 153). The intervention mainly focused on correct medication use, medication adherence and healthy lifestyle promotion. Primary outcome was glycaemic control, as measured by fasting plasma glucose and HbA1c. Sustainability of changes in glycaemic control was assessed by additional glucose measurements 18 months after the end of the study. Results and Discussion: The intervention significantly reduced HbA1c (between-group difference: 0.5%, P = 0.009). The largest impact on HbA1c was observed when pharmacotherapy changes (i.e., type and/or dose of hypoglycaemic agents) initiated by the physician were sustained with pharmaceutical care: HbA1c was reduced by 1.05% in the intervention group, whose medication was changed, compared with a reduction of 0.02% in the therapy-modification only, group. It was also found that the diabetes education program resulted in improved self-management and better knowledge of diabetes. Eighteen months after the end of the formal study period, the mean HbA1c of the intervention group did not differ significantly from the control group (7.4% vs. 7.2%). What is new and Conclusion: This study provides new evidence, from a randomized controlled trial, of the beneficial effect of community pharmacist intervention in the clinical management of type 2 diabetic patients. However, questions remain about the sustainability of the observed improvements.}}, author = {{Mehuys, Els and Van Bortel, Lucas and De Bolle, Leen and Van Tongelen, Inge and Annemans, Lieven and Remon, Jean Paul and Giri, Mimi}}, issn = {{0269-4727}}, journal = {{JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}}, keywords = {{pharmaceutical care,community pharmacy,randomized controlled trial,type 2 diabetes,PHARMACEUTICAL CARE,DRUG-THERAPY,MANAGEMENT,MEDICATION,ADHERENCE,QUALITY,MODEL}}, language = {{eng}}, number = {{5}}, pages = {{602--613}}, title = {{Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial}}, url = {{http://doi.org/10.1111/j.1365-2710.2010.01218.x}}, volume = {{36}}, year = {{2011}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: